BR112023005376A2 - Composições de oligossacarídeos e métodos de uso - Google Patents
Composições de oligossacarídeos e métodos de usoInfo
- Publication number
- BR112023005376A2 BR112023005376A2 BR112023005376A BR112023005376A BR112023005376A2 BR 112023005376 A2 BR112023005376 A2 BR 112023005376A2 BR 112023005376 A BR112023005376 A BR 112023005376A BR 112023005376 A BR112023005376 A BR 112023005376A BR 112023005376 A2 BR112023005376 A2 BR 112023005376A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- compositions
- oligosaccharides
- oligosaccharide compositions
- oligosaccharide
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 229920001542 oligosaccharide Polymers 0.000 title abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 4
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
COMPOSIÇÕES DE OLIGOSSACARÍDEOS E MÉTODOS DE USO. Aspectos da divulgação referem-se a composições de oligossacarídeos e métodos para preparar as mesmas. Também são fornecidos métodos de uso de composições de oligossacarídeos como terapias metabólicas de microbioma para diminuir a inflamação para o tratamento de distúrbios e doenças inflamatórias e imunológicas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063083796P | 2020-09-25 | 2020-09-25 | |
PCT/US2021/052098 WO2022067131A1 (en) | 2020-09-25 | 2021-09-24 | Oligosaccharide compositions and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112023005376A2 true BR112023005376A2 (pt) | 2023-04-25 |
Family
ID=80845871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023005376A BR112023005376A2 (pt) | 2020-09-25 | 2021-09-24 | Composições de oligossacarídeos e métodos de uso |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP4216727A1 (pt) |
JP (1) | JP2023542536A (pt) |
KR (1) | KR20230076828A (pt) |
CN (1) | CN116490192A (pt) |
AU (1) | AU2021350104A1 (pt) |
BR (1) | BR112023005376A2 (pt) |
CA (1) | CA3196600A1 (pt) |
WO (1) | WO2022067131A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2021001716A (es) | 2018-08-15 | 2021-05-31 | Cambridge Glycoscience Ltd | Composiciones novedosas, su uso y metodos para su formacion. |
WO2021032647A1 (en) | 2019-08-16 | 2021-02-25 | Cambridge Glycoscience Ltd | Methods of treating biomass to produce oligosaccharides and related compositions |
WO2021116437A2 (en) | 2019-12-12 | 2021-06-17 | Cambridge Glycoscience Ltd | Low sugar multiphase foodstuffs |
WO2023242184A1 (en) * | 2022-06-14 | 2023-12-21 | Dsm Ip Assets B.V. | Separation of human milk oligosaccharides from a fermentation broth |
WO2024043298A1 (ja) * | 2022-08-25 | 2024-02-29 | 株式会社明治 | 腸内細菌叢改善用組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018513196A (ja) * | 2015-04-23 | 2018-05-24 | カレイド・バイオサイエンシズ・インコーポレイテッド | マイクロバイオーム制御因子及び関連するその使用 |
US20210198302A1 (en) * | 2018-08-21 | 2021-07-01 | Kaleido Biosciences, Inc. | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels |
CA3118909A1 (en) * | 2018-11-08 | 2020-05-14 | Kaleido Biosciences, Inc. | Oligosaccharide compositions and methods of use thereof |
-
2021
- 2021-09-24 CA CA3196600A patent/CA3196600A1/en active Pending
- 2021-09-24 BR BR112023005376A patent/BR112023005376A2/pt unknown
- 2021-09-24 CN CN202180065168.9A patent/CN116490192A/zh active Pending
- 2021-09-24 WO PCT/US2021/052098 patent/WO2022067131A1/en active Application Filing
- 2021-09-24 KR KR1020237013794A patent/KR20230076828A/ko unknown
- 2021-09-24 AU AU2021350104A patent/AU2021350104A1/en active Pending
- 2021-09-24 EP EP21873570.2A patent/EP4216727A1/en active Pending
- 2021-09-24 JP JP2023518832A patent/JP2023542536A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2023542536A (ja) | 2023-10-10 |
CA3196600A1 (en) | 2022-03-31 |
KR20230076828A (ko) | 2023-05-31 |
EP4216727A1 (en) | 2023-08-02 |
AU2021350104A1 (en) | 2023-06-08 |
AU2021350104A9 (en) | 2024-05-23 |
WO2022067131A1 (en) | 2022-03-31 |
CN116490192A (zh) | 2023-07-25 |
WO2022067131A9 (en) | 2022-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112023005376A2 (pt) | Composições de oligossacarídeos e métodos de uso | |
PH12020500240A1 (en) | Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies | |
SA518392101B1 (ar) | ROR-Gamma مشتقات البنزيميدازول في صورة مُعدلات لـ | |
SA518391624B1 (ar) | Ror- منظمات جاما | |
MX2021001439A (es) | Composiciones y metodos para el tratamiento de la disfuncion de la glandula de meibomio. | |
CO2018005361A2 (es) | Formulaciones inyectables de toxina botulínica y sus métodos de uso que poseen efecto terapéutico o cosmético de larga duración | |
SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
BR112015021888A8 (pt) | inibidores de dna-pk, seus usos e composição farmacêutica | |
EA201692422A1 (ru) | Состав, содержащий пролекарство гемцитабина | |
BR112015018270A2 (pt) | composições que compreendem 15-ohepa e métodos de uso das mesmas | |
BR112019022901A2 (pt) | precursor de linhagem mesenquimal ou células t com imunossupressão intensificada | |
PL410665A1 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
PH12021550872A1 (en) | Therapeutic compounds | |
EA201791814A1 (ru) | Имидазолильные трициклические еноны как антиоксидантные модуляторы воспаления | |
WO2018094300A8 (en) | ANTI-GITR ANTIGEN BINDING PROTEINS AND METHODS OF USE | |
BR112014030534A2 (pt) | composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada | |
WO2015031765A3 (en) | Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections | |
BR112022012684A2 (pt) | Compostos cíclicos e métodos de uso dos mesmos | |
MX2021003643A (es) | Derivados de terpenoides y usos de los mismos. | |
WO2020097568A3 (en) | Oligosaccharide compositions and methods of use thereof | |
WO2020128070A3 (de) | Kollagenhydrolysat zur verwendung gegen hautkrankheiten und darmkrankheiten | |
NZ710949A (en) | Modified glycolipids and methods of making and using the same | |
WO2020041531A3 (en) | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | |
BR112021022293A2 (pt) | Composições de oligossacarídeos e métodos de uso das mesmas | |
BR112019017314A2 (pt) | composições farmacêuticas para terapia de combinação |